🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › New York › Queens

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Queens, NY keessatti

Qorannoo 21 Leukemia Myeloidii Hamaa f Queens fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwell Health/Center for Advanced Medicine, Lake Success · Miili 9 fagaatti
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Queens Hospital Center, Jamaica · Miili 2 fagaatti
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwell Health/Center for Advanced Medicine, Lake Success · Miili 9 fagaatti
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

A Study of CRD3874-SI in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwell Health/Center for Advanced Medicine, Lake Success · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · Miili 9 fagaatti
  • NYU Langone Hospital - Long Island, Mineola · Miili 11 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Namoota walitti qabaa jiraSadarkaa 2
  • Clinical Research Allicance, Westbury · Miili 14 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06824168

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · Miili 9 fagaatti
  • NYU Langone Hospital - Long Island, Mineola · Miili 11 fagaatti
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Cohen Children's Medical Center, Queens
29 Days – 21 Years · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Northwell Health, LLC PRIME, Lake Success · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · Miili 10 fagaatti
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT07392242

A Study of Revumenib and Mezigdomide in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · Miili 10 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · Miili 10 fagaatti
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06017258

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau, Uniondale · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · Miili 10 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07011004

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • New York University Langone Hospital - Long Island, Mineola · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Gur-2026 · NCT06773208

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Queens keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.